Haverskerque, France

Philippe Lefevre

This inventor holds 23 USPTO granted patents and 12 published patent applications, plus 9 CIPO patents and 16 EPO patents, primarily in Pharmaceutical Formulations. Top assignee: Roquette Freres. Active years: 1998-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Philippe Lefevre. Retrieved from https://idiyas.com/inventor/philippe-lefevre

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 23 

% Patents Active = 91.3

 

 

Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 125(Granted Patents)


Location History:

  • Merville, FR (1998 - 2005)
  • Haverskerque, FR (2012 - 2022)

Company Filing History:


Years Active: 1998-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Mannitol
Granulation
Pulverulent
Polyol
Sorbitol
Dextrose
Composition
Binder
Film-Forming
Agglomerates
Crystalline
Viscous
23 patents (USPTO):Explore Patents

Title: Innovations in Pharmaceutical Technology by Philippe Lefevre

Introduction

Philippe Lefevre is a notable inventor based in Haverskerque, France, known for his significant contributions to the field of pharmaceutical technology. With an impressive portfolio of 21 patents, Lefevre focuses on innovative processes and formulations that enhance the efficiency and quality of pharmaceutical products.

Latest Patents

Among his recent innovations, two notable patents stand out. The first, "Compressible and free-flow co-agglomerates of mannitol and granule starch," details a process for creating a coagglomerate of crystalline mannitol and starch. This process includes spray-drying or granulating a mixture of mannitol and suspended starch, resulting in a coagglomerate with specific properties, including a laser volume mean diameter and a mannitol/starch ratio optimized for tablet formulation. The coagglomerate showcases remarkable hardness and flow characteristics, which are critical for manufacturing robust pharmaceutical tablets.

The second patent, "Mannitol granules for direct compression," describes granules utilized for tablet preparation through direct compression, eliminating the need for additional lubricant in the processing phase. This invention not only streamlines production but also includes processes for creating these granules and tablets formed from them, enhancing pharmaceutical manufacturing capabilities.

Career Highlights

Philippe Lefevre has worked with prominent companies, including Roquette Frères, where he has likely drawn from the company’s extensive expertise in starches and excipients. His experiences at Roquette Frères have played an instrumental role in shaping his innovative approaches to pharmaceutical product development.

Collaborations

Throughout his career, Lefevre has collaborated with notable professionals such as Baptiste Boit and Erik Labergerie. These collaborations have likely facilitated cross-disciplinary insights and advancements within his patented technologies, contributing to significant improvements in pharmaceutical formulations.

Conclusion

Philippe Lefevre's contributions to the field of pharmaceutical technology through his 21 patents demonstrate a commitment to innovation and excellence. His developments in mannitol-based formulations have paved the way for advancements in the efficiency and effectiveness of pharmaceutical manufacturing, showcasing the importance of innovation in improving healthcare products.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…